Page last updated: 2024-08-22

angiotensin ii and Vascular Diseases

angiotensin ii has been researched along with Vascular Diseases in 111 studies

Research

Studies (111)

Timeframe	Studies, this research(%)	All Research%
pre-1990	31 (27.93)	18.7374
1990's	8 (7.21)	18.2507
2000's	30 (27.03)	29.6817
2010's	32 (28.83)	24.3611
2020's	10 (9.01)	2.80

Authors

Authors	Studies
Alvarado-Ojeda, ZA; Arrellín-Rosas, G; Castro-Martínez, G; Cervantes-Torres, J; Costet-Mejía, A; Fragoso, G; Hernández-Téllez, B; Herrera-Ruiz, M; Jiménez-Ferrer, E; Medina-Campos, ON; Méndez-Martínez, M; Pedraza-Chaverri, J; Ramírez-Pliego, O; Rosas-Salgado, G; Santana, MA; Trejo-Moreno, C	1
Gaikwad, AB; Kulkarni, YA; Mulay, SR; Rao, PD; Sankrityayan, H; Shelke, V	1
Adamaki, M; Cherneva, R; Dabchev, K; Hadjiolova, R; Kadiyska, T; Mitev, V; Spandidos, DA; Stoynev, N; Tourtourikov, I; Zoumpourlis, V	1
Chen, C; Ding, H; Gao, J; Liu, Y; Qian, J; Quarm, AK; Sun, J; Sun, T; Xi, S; Zhang, D	1
Domenig, O; Hartl, L; Hecking, M; Jachs, M; Mandorfer, M; Marculescu, R; Paternostro, R; Poglitsch, M; Reiberger, T; Reindl-Schwaighofer, R; Rumpf, B; Simbrunner, B; Trauner, M	1
Anand, P; Bhati, P; Deepak, KK; Hussain, ME; Masood, S	1
Huang, M; Li, W; Song, T; Zhao, M; Zheng, L; Zhou, M	1
Furgeson, SB; Jolly, AJ; Lu, S; Moulton, KS; Mutryn, MF; Nemenoff, RA; Strand, KA; Tucker, RM; Weiser-Evans, MCM	1
Davidge, ST; Kirschenman, R; Sáez, T; Sawamura, T; Spaans, F	1
Seltzer, S	1
Bo, L; Fan, X; Feng, X; Gao, Q; Gu, X; He, A; Jiang, L; Li, N; Shi, R; Wu, J; Xu, Z; Yang, Y	1
Bautista-Niño, PK; Brandt, RMC; Danser, AHJ; Dollé, MET; Durik, M; Essers, J; Hoeijmakers, JHJ; Leijten, FPJ; Reiling, E; Ridwan, Y; Roks, AJM; van der Pluijm, I; van Steeg, H; van Thiel, BS; Vermeij, WP; Wu, H	1
De Silva, TM; Faraci, FM; Hu, C; Kinzenbaw, DA; Modrick, ML; Sigmund, CD	1
Cunard, R	1
Arrellín, G; Barrita-Cruz, GJ; Castro-Martínez, G; Fragoso, G; Hernández, B; Jiménez-Ferrer, JE; Lombardo-Earl, G; Medina-Campos, ON; Méndez-Martínez, M; Pedraza-Chaverri, J; Ramírez, CC; Rosas, G; Santana, MA; Trejo-Moreno, C; Zamilpa, A	1
Arranz, C; Caniffi, C; Elesgaray, R; Gobetto, MN; Juriol, LV; Mendes Garrido Abregú, F; Tomat, AL	1
Chen, J; Chen, MF; Gong, F; Hong, P; Li, C; Qian, ZJ; Sun, S; Zhou, C	1
Bullen, ML; Chrissobolis, S; Drummond, GR; Hooker, EU; Kemp-Harper, BK; Ku, JM; Maxwell, KF; Michael De Silva, T; Miller, AA; Selemidis, S; Sobey, CG	1
Becker, C; Brandt, M; Daiber, A; Grabbe, S; Hausding, M; Hu, H; Karbach, SH; Knorr, M; Kossmann, S; Kröller-Schön, S; Münzel, T; Oelze, M; Schmidgen, MI; Schönfelder, T; Schwenk, M; Wenzel, P	1
Balus, SF; Buelow, MW; Delaney, M; Dondlinger, L; Hoeppner, C; Lombard, JH; McEwen, ST; Priestley, JR; Weinberg, BD	1
Babelova, A; Benkhoff, S; Brandes, RP; Fleming, I; Leisegang, MS; Loot, AE; Muntean, DM; Schröder, K; Schulz, R; Sturza, A	1
Du, J; Jia, L; Li, Y; Ma, X	1
Becker, C; Daiber, A; Daub, S; Grabbe, S; Hausding, M; Jansen, T; Jurk, K; Kerahrodi, JG; Kossmann, S; Kröller-Schön, S; Mikhed, Y; Münzel, T; Oelze, M; Reske-Kunz, AB; Schulz, E; Schwenk, M; Stein, J; Wenzel, P	1
Heron, RJ	1
Baraldi Araújo Restini, C; Pernomian, L	1
Baek, SH; Choi, HY; Choi, SH; Joo, HB; Kwon, SM; Lee, SJ; Park, JH	1
Diep, H; Drummond, GR; Spizzo, I; Vinh, A; Wei, Z; Widdop, RE	1
Bezold, KY; Cancelas, JA; Chang, KH; Hill, SE; Inagami, T; Loberg, A; Malik, P; Nayak, RC; Perumbeti, A; Pirman, M; Roy, S; Starnes, J; Wellendorf, AM; Zheng, Y; Zhou, X	1
Li, J; Li, M; Liu, X; Meng, G	1
Chen, C; Duan, W; Huang, L; Lu, D; Tan, Y; Tang, L; Wang, S; Zhou, Q	1
Qin, Z	1
Horiuchi, M; Iwai, M; Min, LJ; Mogi, M	1
Hashimoto, T; Ichiki, T; Inanaga, K; Matsuura, H; Miyazaki, R; Sunagawa, K; Takeda, K	1
Ikeda, H; Jin, D; Miyazaki, M; Sakonjo, H; Takai, S	1
Blinder, Y; Guzik, TJ; Harrison, DG; Iwakura, Y; Lob, HE; Madhur, MS; McCann, LA	1
Lakatta, EG; Monticone, RE; Wang, M	1
Al Ghouleh, I; Cascino, T; Csanyi, G; Haurani, MJ; Montezano, AC; Pagano, PJ; Touyz, RM	1
Tsuda, K	1
Burger, D; Montezano, A; Nishigaki, N; Savoia, C; Touyz, RM	1
Chang, SK; Sun, C; Yao, F	1
Geem, D; Harrison, DG; Lob, HE; Marvar, PJ; Ressler, KJ; Thabet, S; Vinh, A	1
Boydens, C; Decaluwé, K; Maenhaut, N; Pauwels, B; Van de Voorde, J	1
Brown, NJ; Cohen, SE; Fogo, AB; Kim, HS; Luo, P; Luther, JM; Wang, Z	1
Brem, AS	1
Mitsuyama, S	1
Briet, M; Ebrahimian, T; Gonzalez, FJ; Kasal, DA; Leibowitz, A; Marchesi, C; Neves, MF; Offermanns, S; Paradis, P; Rautureau, Y; Rehman, A; Schiffrin, EL; Simeone, SM	1
Griendling, KK; Hanna, IR; Rocic, P; Szöcs, K; Taniyama, Y	1
Schiffrin, EL; Virdis, A	1
Takai, S	1
Miyazaki, M; Takai, S	2
Alcázar, R; Egido, J; Ruiz-Ortega, M	1
Cassis, L; Daugherty, A	1
Touyz, RM	1
MacLeod, KM; McNeill, JH; Nagareddy, PR; Xia, Z	1
Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H	1
Kim, HH; Liao, JK; Noma, K; Oyama, N; Rikitake, Y; Satoh, M; Wang, CY	1
Hara, S	1
Clempus, RE; Griendling, KK	1
Griendling, KK; Mehta, PK	1
Cohn, JN	1
de Ronde, W; van den Meiracker, AH	1
Brasier, AR; Buja, LM; Estrera, AL; Guo, D; Liu, Y; Marian, AJ; Milewicz, DM; Pannu, H; Papke, CL; Presley, C; Raman, CS; Safi, HJ; Scherer, S; Tran-Fadulu, V; Vick, GW	1
Brown, KA; Dikalov, S; Goronzy, J; Guzik, TJ; Harrison, DG; Hoch, NE; McCann, LA; Rahman, A; Weyand, C	1
Cripps, MW; Cureton, EL; Curran, B; Ereso, AQ; Ramirez, RM; Sadjadi, J; Victorino, GP	1
Dikalov, SI; Doughan, AK; Harrison, DG	1
Caldwell, RW; Elam, JT; Mecca, TE; Nash, CB	1
Drury, PL	1
Gross, F; Hackenthal, E; Mittmann, U; Murray, RD	1
Dzau, VJ	2
Azagami, S; Morimatsu, M; Murahashi, N; Sasaguri, Y; Takagishi, T	1
Herzer, WA; Jackson, EK; Kost, CK; Li, P	1
Lee, AF; Struthers, AD	1
Moreau, P	1
Chung, O; Unger, T	1
Santoso, T	1
Adler, GK; Kifor, I; Ochoa-Maya, MR; Rennke, HG; Rocha, R; Stier, CT; Williams, GH	1
Dechend, R; Fiebeler, A; Haller, H; Luft, FC; Müller, DN; Park, JK	1
Egido, J; Esteban, V; Lorenzo, O; Mezzano, S; Plaza, JJ; Ruiz-Ortega, M; Rupérez, M; Suzuki, Y	1
Bernstein, KE; Sayeski, PP	1
Chen, Q; Feng, L; Gordon, KL; Han, L; Johnson, RJ; Kanellis, J; Kang, DH; Lan, HY; Mazzali, M; Nakagawa, T; Watanabe, S; Xia, YY	1
Brunner, HR; Cote, LJ; Gavras, H; Gavras, I; Koss, M; Laragh, JH; Vaughan, ED	1
McGiff, JC	1
Beevers, DG; Brown, JJ; Davies, DL; Ferriss, JB; Fraser, R; Lever, AF; Mason, P; Neville, AM; Robertson, JI	1
Beilin, LJ; Goldby, FS; Mohring, J	1
Geise, J	1
Dietz, R; Haebara, H; Lüth, B; Mast, G; Nemes, Z; Schömig, A; Szokol, M	1
Thorball, N	1
Farrar, JK; Graham, DI; Jones, JV; MacKenzie, ET; Strandgaard, S	1
Suc, JM	1
Materson, BJ; Perez-Stable, EC	1
MacGilchrist, AJ; Reid, JL; Sumner, D	1
Shimamoto, T	1
Cain, MC; Catt, KJ	1
Koletsky, S; Pritchard, WH; Rivera-Velez, JM	1
Ajzen, H; Payne, RB; Simmons, JL; Woods, JW	1
Enderlin, F; Gigon, JP; Wolff, G	1
Scheitlin, WA	1
Olsen, F	1
Pritchard, JA; Stone, SR; Whalley, PJ	1
Dahn, I; Hallböök, T; Larsen, OA; Lassen, NA; Nilsén, R; Westling, H	1
Bollinger, A	1
Fyhrquist, F; Goodfriend, T	1
Fukiyama, K; Omae, T	1
Gundersen, J	1
Khairallah, PA; Robertson, AL	1
Giese, J	1
Svendsen, UG	1
Brunner, HR; Gavras, H	1
Eto, T; Omae, T; Oniki, H; Onoyama, K; Tanaka, K	1

Reviews

35 review(s) available for angiotensin ii and Vascular Diseases

Article	Year
Endoplasmic Reticulum Stress and Renin-Angiotensin System Crosstalk in Endothelial Dysfunction. Current molecular pharmacology, 2023, Volume: 16, Issue:2 Topics: Angiotensin II; Endoplasmic Reticulum Stress; Endothelium, Vascular; Humans; Renin-Angiotensin System; Vascular Diseases	2023
Role of endothelial dysfunction in the severity of COVID‑19 infection (Review). Molecular medicine reports, 2022, Volume: 26, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Collagen; COVID-19; Endothelial Cells; Endothelins; Humans; Interleukin-6; Interleukin-8; Nitric Oxide; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptors, Angiotensin; Tumor Necrosis Factor-alpha; Vascular Diseases	2022
Endoplasmic Reticulum Stress, a Driver or an Innocent Bystander in Endothelial Dysfunction Associated with Hypertension? Current hypertension reports, 2017, Volume: 19, Issue:8 Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Endoplasmic Reticulum Stress; Endothelium, Vascular; Humans; Hypertension; Vascular Diseases	2017
Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications. VASA. Zeitschrift fur Gefasskrankheiten, 2014, Volume: 43, Issue:6 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Humans; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Vascular Diseases	2014
Newly developed angiotensin II-infused experimental models in vascular biology. Regulatory peptides, 2008, Oct-09, Volume: 150, Issue:1-3 Topics: Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Blood Vessels; Female; Humans; Hypertension; Inflammation; Mice; Mice, Transgenic; Models, Biological; Neovascularization, Pathologic; Neovascularization, Physiologic; Postmenopause; Pre-Eclampsia; Pregnancy; Vascular Diseases	2008
Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing research reviews, 2009, Volume: 8, Issue:2 Topics: Aging; Aldosterone; Angiotensin II; Animals; Humans; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Vascular Diseases	2009
Arterial aging: a journey into subclinical arterial disease. Current opinion in nephrology and hypertension, 2010, Volume: 19, Issue:2 Topics: Aging; Angiotensin II; Animals; Arteries; Atherosclerosis; Humans; Signal Transduction; Vascular Diseases	2010
Angiotensin II and the vascular phenotype in hypertension. Expert reviews in molecular medicine, 2011, Mar-30, Volume: 13 Topics: Angiotensin II; Humans; Hypertension; Muscle, Smooth, Vascular; Phenotype; Renin-Angiotensin System; Vascular Diseases	2011
[Role of the renin-angiotensin system in the brain and cardiorenal system]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2012, Volume: 140, Issue:3 Topics: Angiotensin II; Animals; Brain Diseases; Cognition Disorders; Endothelium, Vascular; Heart Diseases; Humans; Kidney Diseases; Nitric Oxide Synthase Type III; Oxidative Stress; Renin-Angiotensin System; Stroke; Vascular Diseases	2012
NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxidants & redox signaling, 2002, Volume: 4, Issue:6 Topics: Angiotensin II; Animals; Blood Vessels; Endothelium, Vascular; Humans; Kidney Diseases; Muscle, Smooth, Vascular; NADPH Oxidases; Oxidation-Reduction; Protein Kinases; Reactive Oxygen Species; Signal Transduction; Transcription Factors; Vascular Diseases	2002
Vascular inflammation: a role in vascular disease in hypertension? Current opinion in nephrology and hypertension, 2003, Volume: 12, Issue:2 Topics: Angiotensin II; Arteriosclerosis; Endothelins; Endothelium, Vascular; Female; Humans; Hypertension; Inflammation Mediators; Male; Nitric Oxide; Predictive Value of Tests; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Vascular Diseases; Vascular Endothelial Growth Factor A	2003
[Role of chymase in vascular diseases and the efficacy of chymase inhibitor]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122, Issue:2 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Animals; Blood Pressure; Chymases; Coronary Restenosis; Drug Design; Graft Occlusion, Vascular; Humans; Mast Cells; Serine Endopeptidases; Serine Proteinase Inhibitors; Vascular Diseases	2003
Application of a chymase inhibitor, NK3201, for prevention of vascular proliferation. Cardiovascular drug reviews, 2003,Fall, Volume: 21, Issue:3 Topics: Acetamides; Angioplasty, Balloon; Angiotensin II; Animals; Cell Division; Chymases; Endothelium, Vascular; Graft Occlusion, Vascular; Humans; Hypertension; Protease Inhibitors; Pyrimidines; Serine Endopeptidases; Vascular Diseases	2003
[Angiotensin II : a key peptide in vascular and renal failure]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2003, Volume: 23 Suppl 4 Topics: Angiotensin II; Animals; Clinical Trials as Topic; Humans; Mice; Rats; Renal Insufficiency; Vascular Diseases	2003
Angiotensin II-mediated development of vascular diseases. Trends in cardiovascular medicine, 2004, Volume: 14, Issue:3 Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Arteriosclerosis; Blood Pressure; Disease Models, Animal; Endothelium, Vascular; Humans; Hyperlipidemias; Macrophages; Vascular Diseases	2004
A novel therapeutic strategy against vascular disorders with chymase inhibitor. Current vascular pharmacology, 2003, Volume: 1, Issue:2 Topics: Angioplasty, Balloon; Angiotensin II; Animals; Blood Vessels; Chymases; Enzyme Inhibitors; Graft Occlusion, Vascular; Humans; Hypertension; Serine Endopeptidases; Vascular Diseases	2003
Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Current opinion in nephrology and hypertension, 2005, Volume: 14, Issue:2 Topics: Angiotensin II; Humans; Hypertension; Inflammation; Vascular Diseases	2005
[Uremic syndrome: Pathogenesis, pathophysiology, and therapy]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 2 Topics: Amyloidosis; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Calcinosis; Calcium Channel Blockers; Charcoal; Dialysis; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Failure, Chronic; Toxins, Biological; Uremia; Vascular Diseases	2006
Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovascular research, 2006, Jul-15, Volume: 71, Issue:2 Topics: Angiotensin II; Animals; Cell Differentiation; Cell Movement; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Platelet-Derived Growth Factor; Reactive Oxygen Species; Signal Transduction; Vascular Diseases	2006
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American journal of physiology. Cell physiology, 2007, Volume: 292, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Humans; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction; Structure-Activity Relationship; Vascular Diseases	2007
Diabetes and arterial hypertension. Diabetologia, 1983, Volume: 24, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Diuretics; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Renin; Sodium; Systole; Vascular Diseases	1983
Vascular renin-angiotensin system and vascular protection. Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Vessels; Cell Division; Clinical Trials as Topic; Humans; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Vascular Diseases	1993
Cell biology and genetics of angiotensin in cardiovascular disease. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1994, Volume: 12, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Cardiovascular Diseases; Cell Division; Coronary Disease; Humans; Vascular Diseases; Ventricular Function	1994
The impact of angiotensin converting enzyme inhibitors on the arterial wall. Vascular medicine (London, England), 1996, Volume: 1, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Endothelium, Vascular; Humans; Hyperlipidemias; Hypertension; Sympathetic Nervous System; Vascular Diseases	1996
Endothelin in hypertension: a role for receptor antagonists? Cardiovascular research, 1998, Volume: 39, Issue:3 Topics: Angiotensin II; Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Rats; Vascular Diseases; Vasoconstrictor Agents	1998
Angiotensin II receptor blockade and end-organ protection. American journal of hypertension, 1999, Volume: 12, Issue:12 Pt 1-2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Myocardial Contraction; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium; Vascular Diseases	1999
Angiotensin-induced inflammation and vascular injury. Contributions to nephrology, 2001, Issue:135 Topics: Angiotensin II; Animals; Humans; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity; Vascular Diseases; Vasculitis	2001
Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension (Dallas, Tex. : 1979), 2001, Dec-01, Volume: 38, Issue:6 Topics: Angiotensin II; Angiotensin III; Animals; Apoptosis; Fibrosis; Humans; Kidney; Oxidative Stress; Renin-Angiotensin System; Vascular Diseases	2001
Signal transduction mechanisms of the angiotensin II type AT(1)-receptor: looking beyond the heterotrimeric G protein paradigm. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2001, Volume: 2, Issue:1 Topics: Angiotensin II; Animals; Growth Substances; GTP-Binding Proteins; Humans; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Signal Transduction; Vascular Diseases	2001
Prostaglandins in circulatory disorders. Triangle; the Sandoz journal of medical science, 1979, Volume: 18, Issue:4 Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Diet; Dipyridamole; Eicosanoic Acids; Humans; Hypertension; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases	1979
[Malignant arterial hypertension]. La Nouvelle presse medicale, 1975, Mar-08, Volume: 4, Issue:10 Topics: Aldosterone; Angiotensin II; Antihypertensive Agents; Endarteritis; Female; Humans; Hypertension, Malignant; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Renin; Retinal Diseases; Transplantation, Homologous; Vascular Diseases; Water-Electrolyte Balance	1975
[Renal-vascular hypertension]. Ergebnisse der inneren Medizin und Kinderheilkunde, 1967, Volume: 26 Topics: Adolescent; Adult; Aged; Aneurysm; Angiotensin II; Animals; Aortic Diseases; Arteriovenous Fistula; Child; Embolism; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Radioisotope Renography; Renal Artery; Renal Artery Obstruction; Thrombosis; Vascular Diseases	1967
[Experimental neurogenic hypertension]. Nihon rinsho. Japanese journal of clinical medicine, 1972, Volume: 30, Issue:1 Topics: Angiotensin II; Animals; Aorta; Autonomic Nervous System; Blood Pressure; Brachiocephalic Trunk; Carotid Arteries; Catecholamines; Cats; Cerebral Ventricles; Disease Models, Animal; Dogs; Haplorhini; Hemodynamics; Hot Temperature; Hypertension; Kaolin; Methods; Rabbits; Rats; Subclavian Artery; Sympathectomy; Vascular Diseases	1972
Renin, angiotensin and hypertensive vascular damage: a review. The American journal of medicine, 1973, Volume: 55, Issue:3 Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Capillary Permeability; Dilatation; Hypertension; Ischemia; Macromolecular Substances; Rats; Renal Artery Obstruction; Renin; Vascular Diseases	1973
[Renin and sodium and the formation of vascular lesions in hypertension]. Schweizerische medizinische Wochenschrift, 1974, Sep-21, Volume: 104, Issue:38 Topics: Angiotensin II; Animals; Body Water; Capillary Permeability; Desoxycorticosterone; Dogs; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Mineralocorticoids; Nephrectomy; Rats; Renal Artery Obstruction; Renin; Sodium; Vascular Diseases; Vascular Resistance; Vasoconstrictor Agents	1974

Trials

1 trial(s) available for angiotensin ii and Vascular Diseases

Article	Year
Progressive resistance training ameliorates deteriorating cardiac autonomic dysfunction, subclinical inflammation and endothelial dysfunction in type 2 diabetes mellitus: A randomized control trial. Diabetes & metabolic syndrome, 2023, Volume: 17, Issue:5 Topics: Angiotensin II; Autonomic Nervous System Diseases; Biomarkers; Diabetes Mellitus, Type 2; Humans; Inflammation; Resistance Training; Vascular Diseases	2023

Article

Year

Progressive resistance training ameliorates deteriorating cardiac autonomic dysfunction, subclinical inflammation and endothelial dysfunction in type 2 diabetes mellitus: A randomized control trial.

Diabetes & metabolic syndrome, 2023, Volume: 17, Issue:5

Topics: Angiotensin II; Autonomic Nervous System Diseases; Biomarkers; Diabetes Mellitus, Type 2; Humans; Inflammation; Resistance Training; Vascular Diseases

2023

Other Studies

75 other study(ies) available for angiotensin ii and Vascular Diseases

Article	Year
Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II. Scientific reports, 2021, 10-27, Volume: 11, Issue:1 Topics: Angiotensin II; Animals; Disease Models, Animal; Endothelium, Vascular; Infusions, Parenteral; Intercellular Adhesion Molecule-1; Interleukins; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vascular Diseases; Vascular Remodeling	2021
Cyclophilin D-mediated angiotensin II-induced NADPH oxidase 4 activation in endothelial mitochondrial dysfunction that can be rescued by gallic acid. European journal of pharmacology, 2023, Feb-05, Volume: 940 Topics: Angiotensin II; COVID-19; Gallic Acid; Human Umbilical Vein Endothelial Cells; Humans; Mitochondria; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Peptidyl-Prolyl Isomerase F; Reactive Oxygen Species; Vascular Diseases	2023
The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation. Scientific reports, 2023, 01-18, Volume: 13, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Chymases; Humans; Hypertension, Portal; Inflammation; Liver Cirrhosis; Peptidyl-Dipeptidase A; Prospective Studies; Renin-Angiotensin System; Vascular Diseases	2023
Identification and Screening of Potential ACE2 Activating Peptides from Soybean Protein Isolate Hydrolysate against Ang II-Induced Endothelial Dysfunction. Journal of agricultural and food chemistry, 2023, Aug-09, Volume: 71, Issue:31 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Glycine max; Human Umbilical Vein Endothelial Cells; Humans; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Soybean Proteins; Vascular Diseases	2023
PTEN (Phosphatase and Tensin Homolog) Protects Against Ang II (Angiotensin II)-Induced Pathological Vascular Fibrosis and Remodeling-Brief Report. Arteriosclerosis, thrombosis, and vascular biology, 2020, Volume: 40, Issue:2 Topics: Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Fibrosis; Flow Cytometry; Gene Expression Regulation; Male; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; PTEN Phosphohydrolase; Rats; RNA; Vascular Diseases; Vascular Remodeling	2020
High-cholesterol diet during pregnancy induces maternal vascular dysfunction in mice: potential role for oxidized LDL-induced LOX-1 and AT1 receptor activation. Clinical science (London, England : 1979), 2020, 09-18, Volume: 134, Issue:17 Topics: Angiotensin II; Animals; Aorta; Body Weight; Cholesterol, Dietary; Choline; Endothelium, Vascular; Female; Fetus; Lipoproteins, LDL; Mice, Transgenic; Oxidative Stress; Pregnancy; Receptor, Angiotensin, Type 1; Scavenger Receptors, Class E; Superoxides; Uterine Artery; Vascular Diseases; Vasoconstriction; Vasodilation	2020
Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 101 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Humans; Lung; SARS-CoV-2; Vascular Diseases	2020
Regulation of cerebral arterial BKCa channels by angiotensin II signaling in adult offspring exposed to prenatal high sucrose diets. Bioscience reports, 2017, Jun-30, Volume: 37, Issue:3 Topics: Analysis of Variance; Angiotensin II; Animals; Brain; Calcium; Diet; Dietary Sucrose; Female; Glucose; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Male; Microvessels; Middle Cerebral Artery; Patch-Clamp Techniques; Potassium; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Vascular Diseases; Vasoconstriction	2017
Dietary restriction but not angiotensin II type 1 receptor blockade improves DNA damage-related vasodilator dysfunction in rapidly aging Clinical science (London, England : 1979), 2017, Aug-01, Volume: 131, Issue:15 Topics: Aging; Angiotensin II; Animals; Blood Pressure; Diet; DNA Damage; DNA-Binding Proteins; Endonucleases; Female; Humans; Male; Mice; Mice, Knockout; Nitric Oxide; Receptor, Angiotensin, Type 1; Vascular Diseases; Vasodilation	2017
Genetic Interference With Endothelial PPAR-γ (Peroxisome Proliferator-Activated Receptor-γ) Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1-7. Hypertension (Dallas, Tex. : 1979), 2017, Volume: 70, Issue:3 Topics: Amides; Angiotensin I; Angiotensin II; Animals; Animals, Genetically Modified; Carotid Arteries; Female; Interleukin-6; Male; Mice; NF-kappa B; Oxidative Stress; Peptide Fragments; PPAR gamma; Pyridines; Renin-Angiotensin System; Vascular Diseases; Vasoconstrictor Agents; Vasodilation	2017
Acetone fraction from Sechium edule (Jacq.) S.w. edible roots exhibits anti-endothelial dysfunction activity. Journal of ethnopharmacology, 2018, Jun-28, Volume: 220 Topics: Acetone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Cinnamates; Cucurbitaceae; Disease Models, Animal; Endothelium, Vascular; Fatty Acids; Female; Losartan; Mexico; Mice; Mice, Inbred C57BL; Plant Extracts; Plant Roots; Vascular Diseases	2018
Developmental programming of vascular dysfunction by prenatal and postnatal zinc deficiency in male and female rats. The Journal of nutritional biochemistry, 2018, Volume: 56 Topics: Acetylcholine; Angiotensin II; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Aorta, Thoracic; Calcium; Female; Lactation; Male; Malnutrition; Maternal Nutritional Physiological Phenomena; Micronutrients; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Oxidants; Oxidative Stress; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Systole; Vascular Diseases; Vasoconstrictor Agents; Zinc	2018
In Vitro Vascular-Protective Effects of a Tilapia By-Product Oligopeptide on Angiotensin II-Induced Hypertensive Endothelial Injury in HUVEC by Nrf2/NF-κB Pathways. Marine drugs, 2019, Jul-23, Volume: 17, Issue:7 Topics: Angiotensin II; Animals; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Molecular Docking Simulation; NF-E2-Related Factor 2; NF-kappa B; Oligopeptides; Oxidative Stress; Protein Binding; Signal Transduction; Tilapia; Vascular Diseases	2019
Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity. Free radical biology & medicine, 2013, Volume: 60 Topics: Angiotensin II; Animals; Cerebral Arteries; Humans; Hydrazines; Membrane Glycoproteins; Mice; Molecular Targeted Therapy; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitrogen Oxides; Oxidative Stress; Reactive Oxygen Species; Superoxides; Vascular Diseases	2013
Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cells. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:6 Topics: Angiotensin II; Animals; Aorta; Disease Models, Animal; Endothelium, Vascular; Interferon-gamma; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Monocytes; Oxidative Stress; Random Allocation; Reference Values; Vascular Diseases	2013
Reduced angiotensin II levels cause generalized vascular dysfunction via oxidant stress in hamster cheek pouch arterioles. Microvascular research, 2013, Volume: 89 Topics: Acetylcholine; Angiotensin II; Animals; Arterioles; Blood Pressure; Captopril; Cheek; Cricetinae; Cromakalim; Endothelium, Vascular; Epoprostenol; Glyburide; Iloprost; Male; Mesocricetus; Microscopy; Microscopy, Video; Nitroprusside; Oxidants; Oxygen; Peptidyl-Dipeptidase A; Superoxides; Vascular Diseases	2013
Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension (Dallas, Tex. : 1979), 2013, Volume: 62, Issue:1 Topics: Angiotensin II; Animals; Aorta, Thoracic; Blotting, Western; Disease Models, Animal; Endothelium, Vascular; Gene Expression Regulation; Humans; Immunohistochemistry; Mice; Monoamine Oxidase; Oxidative Stress; Real-Time Polymerase Chain Reaction; RNA, Messenger; Umbilical Veins; Vascular Diseases; Vasodilation	2013
Add another killer for interfered vascular function: natural killer cells-produced interferon-γ is a cue. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:6 Topics: Angiotensin II; Animals; Interferon-gamma; Killer Cells, Natural; Male; Monocytes; Vascular Diseases	2013
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction. Basic research in cardiology, 2013, Volume: 108, Issue:6 Topics: Angiotensin II; Animals; Aorta; Blotting, Western; CD40 Ligand; Endothelial Cells; Flow Cytometry; Immunohistochemistry; Inflammation; Leukocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Platelet Activation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Thrombosis; Vascular Diseases	2013
Response to "The unknown: respiratory effects of cleaning up an oil spill". The Lancet. Respiratory medicine, 2013, Volume: 1, Issue:5 Topics: Angiotensin II; Animals; Endothelial Cells; Mitochondrial Diseases; Oxidative Stress; Vascular Diseases; Vasoconstrictor Agents	2013
Oleuropein prevents angiotensin II-mediated: Human vascular progenitor cell depletion. International journal of cardiology, 2015, Feb-15, Volume: 181 Topics: Angiotensin II; Cell Culture Techniques; Humans; Iridoid Glucosides; Iridoids; Oxidative Stress; Stem Cells; Vascular Diseases; Vasodilator Agents	2015
Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice. PloS one, 2014, Volume: 9, Issue:12 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Humans; Hypertension; Interleukin-17; Interleukin-4; Mice; Phenotype; Reactive Oxygen Species; T-Lymphocytes; Tumor Necrosis Factor-alpha; Vascular Diseases	2014
Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial AT₂R and cytoskeletal dysregulation. Nature communications, 2015, Jan-09, Volume: 6 Topics: Actins; Adaptor Proteins, Signal Transducing; Anemia, Sickle Cell; Angiotensin II; Animals; Bone Marrow Cells; Cell Adhesion; Cell Membrane; Crosses, Genetic; Cytoskeleton; Endothelial Cells; Hematopoiesis; Hematopoietic Stem Cells; Humans; Integrin beta1; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Nitric Oxide; Signal Transduction; Stem Cells; Vascular Diseases	2015
Protective effects of diltiazem against vascular endothelial cell injury induced by angiotensin-II and hypoxia. Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:4 Topics: Angiotensin II; Animals; Apoptosis; Calcitonin Gene-Related Peptide; Calcium Channel Blockers; Calcium Signaling; Cells, Cultured; Cytoprotection; Diltiazem; Disease Models, Animal; Endothelial Cells; Endothelin-1; Humans; Hypoxia; Male; Membrane Potential, Mitochondrial; Mitochondria; Nitric Oxide; Nitric Oxide Synthase Type III; Rats, Wistar; Vascular Diseases	2015
miR-185/P2Y6 Axis Inhibits Angiotensin II-Induced Human Aortic Vascular Smooth Muscle Cell Proliferation. DNA and cell biology, 2017, Volume: 36, Issue:5 Topics: Angiotensin II; Aorta; Cell Proliferation; Cells, Cultured; Down-Regulation; HEK293 Cells; Humans; Hypertension; MAP Kinase Signaling System; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptors, Purinergic P2; Vascular Diseases	2017
Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis. Hypertension research : official journal of the Japanese Society of Hypertension, 2009, Volume: 32, Issue:6 Topics: Angiotensin II; Animals; Antioxidants; Blood Pressure; Blotting, Northern; Blotting, Western; Body Weight; Cells, Cultured; DNA; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart Rate; Interleukin-6; Luciferases; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Promoter Regions, Genetic; Rats; Resveratrol; Stilbenes; Vascular Diseases	2009
Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2009, Volume: 32, Issue:10 Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carotid Arteries; Hypertension; Imidazoles; Immunohistochemistry; In Vitro Techniques; Male; Muscle Relaxation; NADPH Oxidases; Peptidyl-Dipeptidase A; Protective Agents; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Tetrazoles; Valine; Valsartan; Vascular Diseases	2009
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:2 Topics: Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Cohort Studies; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Humans; Hypertension; Interleukin-17; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Probability; Random Allocation; Reference Values; T-Lymphocytes; Vascular Diseases	2010
Adventitia-derived hydrogen peroxide impairs relaxation of the rat carotid artery via smooth muscle cell p38 mitogen-activated protein kinase. Antioxidants & redox signaling, 2011, Sep-15, Volume: 15, Issue:6 Topics: Angiotensin II; Animals; Carotid Arteries; Catalase; Connective Tissue; Disease Models, Animal; Hydrogen Peroxide; Imidazoles; Male; Muscle Relaxation; Myocytes, Smooth Muscle; Myography; p38 Mitogen-Activated Protein Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Pyridines; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vascular Diseases	2011
Regarding article "Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction". Stroke, 2011, Volume: 42, Issue:2 Topics: Angiotensin II; Animals; Calcitonin Gene-Related Peptide; Cerebrovascular Disorders; Humans; Receptor Activity-Modifying Protein 1; Vascular Diseases	2011
Lentil polyphenol extract prevents angiotensin II-induced hypertension, vascular remodelling and perivascular fibrosis. Food & function, 2012, Volume: 3, Issue:2 Topics: Administration, Oral; Angiotensin II; Animals; Aorta; Drinking; Fibrosis; Heart; Hypertension; Kidney; Lens Plant; Male; Plant Extracts; Polyphenols; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vascular Diseases	2012
T lymphocytes and vascular inflammation contribute to stress-dependent hypertension. Biological psychiatry, 2012, May-01, Volume: 71, Issue:9 Topics: Adoptive Transfer; Angiotensin II; Animals; Blood Pressure; Corticotropin-Releasing Hormone; Gene Expression Regulation; Genes, RAG-1; Hypertension; Inflammation; Lymphocyte Activation; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Stress, Psychological; T-Lymphocytes; Vascular Diseases	2012
Adipose tissue as regulator of vascular tone. Current hypertension reports, 2012, Volume: 14, Issue:3 Topics: Adipocytes; Adipokines; Adipose Tissue; Angiotensin II; Humans; Inflammation Mediators; Muscle, Smooth, Vascular; Obesity; Vascular Diseases	2012
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney international, 2012, Volume: 82, Issue:6 Topics: Aldosterone; Angiotensin II; Animals; Aorta; Biomarkers; Blood Pressure; Cytochrome P-450 CYP11B2; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Diseases; Inflammation; Kidney Diseases; Kidney Glomerulus; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Myocardium; Receptors, Mineralocorticoid; Renin-Angiotensin System; Sodium Chloride, Dietary; Spironolactone; Time Factors; Vascular Diseases	2012
Targeting activated mineralocorticoid receptor: Occam's razor revisited. Kidney international, 2012, Volume: 82, Issue:6 Topics: Aldosterone; Angiotensin II; Animals; Heart Diseases; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Spironolactone; Vascular Diseases	2012
Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. Cardiovascular research, 2013, Mar-01, Volume: 97, Issue:3 Topics: Angiotensin II; Animals; Chemokine CCL2; Disease Models, Animal; Endothelium, Vascular; Hypertension; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; NADP; Oxidative Stress; PPAR gamma; Superoxide Dismutase; Vascular Diseases	2013
Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:5 Topics: Amidines; Angiotensin II; Animals; Benzylamines; Blood Pressure; Blotting, Western; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Heart Rate; Hemodynamics; Immunohistochemistry; Male; Methoxamine; Neurotensin; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Vascular Diseases; Vasoconstrictor Agents	2005
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. American journal of hypertension, 2005, Volume: 18, Issue:7 Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance	2005
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation, 2005, Nov-08, Volume: 112, Issue:19 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Protein Serine-Threonine Kinases; Quaternary Ammonium Compounds; rho-Associated Kinases; Vascular Diseases	2005
What is the role of angiotensin-receptor blockade in cardiovascular protection? American heart journal, 2006, Volume: 152, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Endothelium, Vascular; Humans; Kidney Diseases; Pilot Projects; Renin-Angiotensin System; Research Design; Vascular Diseases; Ventricular Remodeling	2006
Gender differences in vascular disease: not a simple explanation. Journal of hypertension, 2007, Volume: 25, Issue:6 Topics: Angiotensin II; Animals; Female; Humans; Hypertension; Male; Mice; NADPH Oxidases; Sex Characteristics; Thioredoxins; Vascular Diseases	2007
MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Human molecular genetics, 2007, Oct-15, Volume: 16, Issue:20 Topics: Adult; Amino Acid Sequence; Angiotensin II; Aortic Aneurysm, Thoracic; Child, Preschool; Ductus Arteriosus, Patent; Female; Genetic Testing; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Models, Molecular; Molecular Sequence Data; Mutation; Myosin Heavy Chains; Pedigree; Sequence Homology, Amino Acid; Vascular Diseases	2007
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. The Journal of experimental medicine, 2007, Oct-01, Volume: 204, Issue:10 Topics: Angiotensin II; Animals; Cell Movement; Hypertension; Lymphocyte Activation; Mice; Mice, Knockout; NADPH Oxidases; T-Lymphocytes; Vascular Diseases	2007
Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak. Journal of the American College of Surgeons, 2007, Volume: 205, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Capillary Permeability; Endothelium, Vascular; Female; Inflammation; Mesenteric Veins; Microcirculation; Models, Animal; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Vascular Diseases	2007
Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circulation research, 2008, Feb-29, Volume: 102, Issue:4 Topics: Angiotensin II; Animals; Aorta; Cattle; Cell Respiration; Cells, Cultured; Endothelial Cells; Glutathione; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Nitric Oxide; Oxidative Stress; Superoxides; Vascular Diseases; Vasoconstrictor Agents	2008
alpha-Adrenergic blocking properties of quinine HCl. European journal of pharmacology, 1980, May-02, Volume: 63, Issue:2-3 Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Aorta; Blood Pressure; Calcium; Cardiovascular System; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Myocardial Contraction; Norepinephrine; Quinidine; Quinine; Rabbits; Vascular Diseases; Vasoconstrictor Agents	1980
Contralateral renal function following unilateral renal artery constriction. Renal physiology, 1982, Volume: 5, Issue:6 Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Constriction, Pathologic; Dogs; Female; Kidney; Male; Renal Artery; Renin; Vascular Diseases	1982
Effect of angiotensin II and thromboxane A2 on the production of matrix metalloproteinase by human aortic smooth muscle cells. Biochemistry and molecular biology international, 1995, Volume: 35, Issue:2 Topics: Angiotensin II; Aorta, Thoracic; Calcium; Cell Division; Cells, Cultured; Collagenases; DNA; Enzyme Precursors; Humans; Inositol 1,4,5-Trisphosphate; Kinetics; Matrix Metalloproteinase 1; Muscle, Smooth, Vascular; Thromboxane A2; Thymidine; Vascular Diseases	1995
Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1 Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Captopril; Cardiac Output; Heart Rate; Hypertension; Infusions, Intravenous; Kidney; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity; Vascular Diseases; Vascular Resistance	1994
Improvement of endothelial dysfunction as a surrogate endpoint in the treatment of hypertension. Current hypertension reports, 2000, Volume: 2, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diagnostic Imaging; Endothelium, Vascular; Humans; Hypertension; NF-kappa B; Nitric Oxide; Vascular Diseases; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2000
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology, 2000, Volume: 141, Issue:10 Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Enzyme Inhibitors; Eplerenone; Hormone Antagonists; Kidney; Male; Myocardium; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Renal Artery; Renin; Sodium Chloride; Spironolactone; Vascular Diseases	2000
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. American journal of physiology. Renal physiology, 2002, Volume: 282, Issue:6 Topics: Administration, Oral; Allopurinol; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Benzofurans; Blood Pressure; Diuretics; Enalapril; Hydrochlorothiazide; Hypertension; Kidney; Losartan; Male; Muscle, Smooth, Vascular; Oxonic Acid; Rats; Rats, Sprague-Dawley; Sodium Chloride Symporter Inhibitors; Sodium Chloride, Dietary; Uric Acid; Uricosuric Agents; Vascular Diseases	2002
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circulation research, 1975, Volume: 36, Issue:2 Topics: Alanine; Angiotensin II; Animals; Blood Pressure; Body Weight; Corticosterone; Hematocrit; Hypertension, Malignant; Kidney; Male; Myocardium; Norepinephrine; Potassium; Rats; Renin; Sarcosine; Sodium; Sodium Chloride; Vascular Diseases	1975
Clinical, biochemical and pathological features of low-renin ("primary") hyperaldosteronism. American heart journal, 1978, Volume: 95, Issue:3 Topics: 18-Hydroxydesoxycorticosterone; Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Aging; Angiotensin II; Angiotensinogen; Carbon Dioxide; Corticosterone; Desoxycorticosterone; Female; Humans; Hyperaldosteronism; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Potassium; Renin; Sodium; Urea; Vascular Diseases	1978
High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension. Clinical science and molecular medicine, 1977, Volume: 52, Issue:2 Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Capillary Permeability; Humans; Hypertension, Malignant; Necrosis; Renin; Vascular Diseases; Vasopressins	1977
The renin-angiotensin system and the pathogenesis of vascular disease in malignant hypertension. Clinical science and molecular medicine. Supplement, 1976, Volume: 3 Topics: Angiotensin II; Animals; Arteries; Humans; Hypertension, Malignant; Kidney; Microcirculation; Renin; Secretory Rate; Vascular Diseases	1976
Does the renin-angiotensin system contribute to the vascular lesions in renal hypertensive rats? Clinical science and molecular medicine. Supplement, 1976, Volume: 3 Topics: Angiotensin II; Animals; Cerebrovascular Disorders; Hypertension, Renal; Rats; Renal Artery; Renin; Sodium; Vascular Diseases	1976
Ultrastructural arteriolar lesions and permeability changes in acute angiotensin-induced hypertension. Acta medica Scandinavica. Supplementum, 1976, Volume: 602 Topics: Acute Disease; Angiotensin II; Animals; Arteries; Cell Membrane Permeability; Hypertension; Intestine, Small; Rats; Vascular Diseases; Vascular Resistance	1976
The sausage-string pattern in the pial vessels in acute, angiotensin-induced hypertension--vasospasm or vasodilatation? Acta medica Scandinavica. Supplementum, 1976, Volume: 602 Topics: Angiotensin II; Animals; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Homeostasis; Hypertension; Pia Mater; Rats; Vascular Diseases; Vasomotor System	1976
Workup of the newly discovered hypertensive patient. Postgraduate medicine, 1975, Volume: 57, Issue:3 Topics: Adult; Aldosterone; Angiotensin II; Cardiac Output; Cerebrovascular Disorders; Contraceptives, Oral; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Mass Screening; Medical History Taking; Middle Aged; Pheochromocytoma; Renin; United States; Uremia; Urography; Vascular Diseases	1975
Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology (Baltimore, Md.), 1991, Volume: 13, Issue:4 Topics: Adult; Aged; Angiotensin II; Blood Pressure; Female; Heart Rate; Humans; Isoproterenol; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Nordefrin; Norepinephrine; Phenylephrine; Reference Values; Vascular Diseases	1991
Injury and repair in arterial tissue: contraction and blebbing of endothelial cells in atherogenesis and thrombogenesis and abnormal secretion of sex hormone in Takayasu's disease. Angiology, 1974, Volume: 25, Issue:10 Topics: Adolescent; Adult; Angiotensin II; Animals; Aorta; Aortic Arch Syndromes; Arteries; Arteriosclerosis; Cholesterol; Endothelium; Epinephrine; Estrogens; Female; Fluorescent Antibody Technique; gamma-Globulins; Gonadal Steroid Hormones; Humans; Lipoproteins, LDL; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Pregnanediol; Rabbits; Regeneration; Takayasu Arteritis; Thrombosis; Vascular Diseases	1974
Measurement of angiotensin II in blood. Lancet (London, England), 1967, Nov-11, Volume: 2, Issue:7524 Topics: Angiotensin II; Animals; Blood Pressure; Humans; Hypertension; Immune Sera; Iodine Radioisotopes; Nephritis; Rabbits; Radioimmunoassay; Vascular Diseases	1967
Production of hypertension and vascular disease by angiotensin. Archives of pathology, 1966, Volume: 82, Issue:1 Topics: Angiotensin II; Animals; Hypertension, Renal; Rats; Vascular Diseases	1966
The angiotensin infusion test. The Journal of urology, 1966, Volume: 96, Issue:2 Topics: Adult; Angiotensin II; Aortic Coarctation; Blood Pressure Determination; Diagnosis, Differential; Humans; Hypertension; Hypertension, Renal; Renal Artery Obstruction; Vascular Diseases	1966
[Shock therapy with vasodilator and-or vasoconstrictor agents]. Helvetica chirurgica acta, 1967, Volume: 34, Issue:1 Topics: Adult; Aged; Angiotensin II; Blood Pressure; Diuresis; Female; Humans; Isoproterenol; Norepinephrine; Sepsis; Shock; Vascular Diseases; Vasoconstrictor Agents; Vasodilator Agents	1967
Rate and ways of resolution of hypertensive vascular disease. Acta pathologica et microbiologica Scandinavica, 1969, Volume: 77, Issue:1 Topics: Angiotensin II; Animals; Arteries; Blood Cells; Blood Proteins; Carbon; Colloids; Female; Hypertension, Renal; Intestinal Mucosa; Intestine, Small; Intestines; Lymph Nodes; Membranes; Mesentery; Microscopy, Fluorescence; Phagocytosis; Plasma; Rats; Regeneration; Vascular Diseases	1969
Inferior vena cava and ovarian vein ligation during late pregnancy. Obstetrics and gynecology, 1968, Volume: 32, Issue:2 Topics: Abruptio Placentae; Adult; Angiotensin II; Blood Pressure; Blood Volume; Female; Gestational Age; Humans; Kidney; Kidney Function Tests; Male; Ovary; Posture; Pregnancy; Pregnancy Complications, Cardiovascular; Radiography; Vascular Diseases; Veins; Vena Cava, Inferior	1968
[Treating severe arterial insufficiency in the legs by induced hypertension]. Lakartidningen, 1968, Nov-27, Volume: 65, Issue:48 Topics: Angiotensin II; Arteries; Humans; Hypertension; Ischemia; Leg; Mineralocorticoids; Regional Blood Flow; Vascular Diseases	1968
[Internal therapy of peripheral arterial blood circulation disorders]. Schweizerische medizinische Wochenschrift, 1970, May-02, Volume: 100, Issue:18 Topics: Adenosine Triphosphate; Aged; Angiotensin II; Anti-Bacterial Agents; Blood Pressure; Chlorpromazine; Chronic Disease; Collateral Circulation; Coumarins; Epinephrine; Ergot Alkaloids; Exercise Therapy; Femoral Artery; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Methoxamine; Nicotinic Acids; Papaverine; Popliteal Artery; Propranolol; Reserpine; Sympatholytics; Sympathomimetics; Thrombosis; Vascular Diseases	1970
Angiotensin binding by receptor-like factors in plasma from seriously ill patients and an experimental dog model. The Journal of laboratory and clinical medicine, 1971, Volume: 78, Issue:5 Topics: Angiotensin II; Animals; Constriction; Disease Models, Animal; Dogs; Humans; Ischemia; Receptors, Drug; Time Factors; Vascular Diseases	1971
Pitfalls in drip-infusion technique. A new device for automatic control of infusion rate. Acta anaesthesiologica Scandinavica, 1972, Volume: 16, Issue:2 Topics: Angiotensin II; Blood Transfusion; Electronics, Medical; Humans; Injections, Intravenous; Methods; Solutions; Streptodornase and Streptokinase; Thrombophlebitis; Vascular Diseases	1972
Arterial endothelial permeability and vascular disease. The "trap door" effect. Experimental and molecular pathology, 1973, Volume: 18, Issue:2 Topics: Angiotensin II; Animals; Aorta, Thoracic; Arteries; Arteriosclerosis; Blood Platelets; Bradykinin; Capillary Permeability; Endothelium; Female; Intercellular Junctions; Lipoproteins; Macromolecular Substances; Microscopy, Electron; Norepinephrine; Rats; Serotonin; Thrombosis; Vascular Diseases	1973
Increased cellular reaction to damage caused by angiotensin in arterioles of normal recipient rats after transfer of lymphocytes from hypertensive rats. Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1973, Volume: 81, Issue:3 Topics: Angiotensin II; Animals; Female; Hypertension, Renal; Immunity, Cellular; Immunologic Memory; Lymphocyte Transfusion; Mesenteric Arteries; Rats; Stimulation, Chemical; Thoracic Duct; Time Factors; Transplantation, Homologous; Vascular Diseases	1973
The kidney factors in the production of acute hypertensive vascular lesions. Japanese circulation journal, 1974, Volume: 38, Issue:12 Topics: Acute Disease; Angiotensin II; Animals; Arteries; Edema; Female; Fluorescent Antibody Technique; Hypertension; Injections; Kidney Cortex; Lysosomes; Mitochondria; Necrosis; Nephrectomy; Pancreas; Pleural Effusion; Rabbits; Rats; Renin; Solubility; Subcellular Fractions; Tissue Extracts; Vascular Diseases	1974